Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+36.4%
Studio
Year-over-Year Change

Year-over-year net income growth rate

3Y CAGR
+36.4%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
2.5x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202576.64%
2024-14.31%
2023-173.59%
202230.20%
202122.90%
2020-61.30%
2019-36.61%
2018-363.06%
2017-133.09%
20160.00%